CellAura signs major supply deal with Cisbio Bioassays

23-Oct-2009 - United Kingdom

CellAura announced a development partnership with Cisbio bioassays. Under the terms of the agreement, CellAura will provide pharmacologically validated reagents to Cisbio Bioassays that will be applied to Cisbio Bioassays’ Tag-lite™ range of non-radioactive assays for cellular studies.

Commenting on the collaboration, CellAura CEO Dai Hayward said: "Maximising cellular information is increasingly seen as the key to successful drug discovery. CellAura combines world-renowned expertise from the University of Nottingham in the fields of synthetic chemistry and molecular pharmacology to produce high quality fluorescent receptor ligands as key components in drug candidate screening assays and imaging techniques. This new partnership with Cisbio Bioassays, which is one of the leaders in bioassays for cell surface receptor and functional studies, recognizes our rapid progress and is a major milestone."

Other news from the department business & finance

Most read news

More news from our other portals

Fighting cancer: latest developments and advances